Remdesivir Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/ACTIV-3: Therapeutics for Inpatients With COVID-19
https://clinicaltrials.gov/ct2/show/Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal
https://clinicaltrials.gov/ct2/show/Immune Modulators for Treating COVID-19
https://clinicaltrials.gov/ct2/show/Adaptive COVID-19 Treatment Trial 4 (ACTT-4)
https://clinicaltrials.gov/ct2/show/Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting